Evidence map›Paper›PMID 37077556›Full record

ArticleERJ open research2023

ERS International Congress 2022: highlights from the Sleep Disordered Breathing Assembly.

Matteo Bradicich, Matteo Siciliano, Enrico Schiavi, Edoardo Amante, Chloé Cantero, Amany F Elbehairy, Andrea Portacci, Michail Fanaridis, Dries Testelmans, Winfried Randerath and 1 more

Abstract read
In one paragraph

Article in ERJ open research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Matteo BradicichDepartment of Pulmonology, University Hospital Zurich, Zurich, Switzerland.
Matteo SicilianoUniversità Cattolica del Sacro Cuore, Campus di Roma; Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.ORCID https://orcid.org/0000-0002-4913-5796
Enrico SchiaviUniversità Cattolica del Sacro Cuore, Campus di Roma; Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Edoardo AmanteUniversità Cattolica del Sacro Cuore, Campus di Roma; Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Chloé CanteroService de Pneumologie (Département R3S), APHP, Groupe Hospitalier Universitaire APHP-Sorbonne Université, Site Pitié-Salpêtrière, Paris, France.
Amany F ElbehairyDivision of Infection, Immunity and Respiratory Medicine, The University of Manchester, and Manchester University NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK.ORCID https://orcid.org/0000-0001-5180-519X
Andrea PortacciDepartment of Basic Medical Science, Neuroscience and Sense Organs, Institute of Respiratory Disease, University "Aldo Moro", Bari, Italy.ORCID https://orcid.org/0000-0002-6127-2486
Michail FanaridisDepartment of Respiratory Medicine, University Hospital of Heraklion, Heraklion, Greece.ORCID https://orcid.org/0000-0002-9226-4745
Dries TestelmansDepartment of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium.ORCID https://orcid.org/0000-0001-7303-9799
Winfried RanderathInstitute of Pneumology at the University of Cologne, Bethanien Hospital, Solingen, Germany.ORCID https://orcid.org/0000-0002-5010-8461
Sophia SchizaDept of Respiratory Medicine, Sleep Disorders Centre, School of Medicine, University of Crete, Heraklion, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During the European Respiratory Society (ERS) International Congress 2022 in Barcelona, Spain, the latest research and clinical topics in respiratory medicine were presented. The sleep medicine-focused presentations and symposia provided novel insights into the pathophysiology of sleep disordered breathing, its diagnostics, and new trends in translational research and clinical applications. The presented research trends focused mainly on the assessment of sleep disordered breathing-related intermittent hypoxia, inflammation and sleep fragmentation, and their implications, especially cardiovascular. The most promising methods for assessing these aspects encompass genomics, proteomics and cluster analysis. The currently available options include positive airway pressure and a combination of it and pharmacological agents (

Identifiers

PMID37077556
PMCPMC10107067

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.